ARUP's Laboratory Test Directory

Hepatitis C Virus Antibody (RIBA), Supplemental : 0020104

Mnemonic: HCVAB RIBA

Methodology: Qualitative Recombinant Immunoblot Assay
Performed: Wed-Sat
Reported: 1-4 days
Specimen Required: Collect: Serum separator tube.

Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL) Also acceptable: K2EDTA plasma.

Storage/Transport Temperature: Refrigerated.

Submit specimen according to Biological Substance, Category B, shipping guidelines.


Unacceptable Conditions: Specimens containing particulate material. Heat-inactivated, severely hemolyzed or lipemic specimens.

Stability (collection to initiation of testing): After separation from cells: Ambient: Unacceptable; Refrigerated: 1 week; Frozen: Indefinitely (avoid repeated freeze/thaw cycles)
Reference Interval:
Negative
Interpretive Data: This assay should not be used for blood donor screening, associated re-entry protocols, or for screening Human Cell, Tissues and Cellular and Tissue-Based Products (HCT/P). 
Note: This test is recommended for specimens with prior low positive anti-HCV screening results. For high positive anti-HCV screening results, ARUP recommends collecting a new specimen and testing for hepatitis C RNA by PCR or bDNA.
This test is intended for use in conjunction with clinical presentation and other laboratory markers as an indicator of disease prognosis.  This test is also used as an aid in assessing viral response to antiretroviral treatment as measured by changes in HCV RNA levels.
CPT Code(s): 86804
Cross References: HCV RIBA (Hepatitis C Virus Antibody (RIBA), Supplemental), Recombinant Immunoblot Assay (Hepatitis C Virus Antibody (RIBA), Supplemental)
 
 

 

 

 
All ARUP Sites:        www.aruplab.com     ·     www.arupconsult.com     ·     www.arup.utah.edu     ·     www.childx.org     ·     www.utahblood.org